About the Authors
- Richard M. Gibson
-
Contributed equally to this work with: Richard M. Gibson, Jan Weber
Affiliation University Hospital Translational Laboratory, University Hospitals Case Medical Center, Cleveland, Ohio, United States of America
- Jan Weber
-
Contributed equally to this work with: Richard M. Gibson, Jan Weber
Affiliation Institute of Organic Chemistry and Biochemistry, Prague, Czech Republic
- Dane Winner
-
Affiliation University Hospital Translational Laboratory, University Hospitals Case Medical Center, Cleveland, Ohio, United States of America
- Michael D. Miller
-
Affiliation Gilead Sciences, Inc., Foster City, California, United States of America
- Miguel E. Quiñones-Mateu
-
* E-mail: meq@case.edu
Affiliations University Hospital Translational Laboratory, University Hospitals Case Medical Center, Cleveland, Ohio, United States of America, Department of Pathology, Case Western Reserve University, Cleveland, Ohio, United States of America
Competing Interests
R.M.G. and M.E.Q.-M. developed the novel HIV-1 genotyping and coreceptor tropism assay, DEEPGEN HIV. M.D.M. is employed by Gilead Sciences, the developer of elvitegravir, which was used in this study. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.
Author Contributions
Conceived and designed the experiments: MEQM. Performed the experiments: RMG JW DW. Analyzed the data: RMG JW MEQM. Contributed reagents/materials/analysis tools: MDM. Contributed to the writing of the manuscript: MEQM.